Search clinical trials for: Rg3

Total 383 results

PATH
Bill and Melinda Gates Foundation; Children's Hospital Medical Center, Cincinnati and other collaborators

Completed

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Rotavirus Vaccine

South Africa
AbbVie
AbbVie

Recruiting

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

Neovascular Age-Related Macular Degeneration (nAMD)

United States
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
DNAtrix, Inc.

Completed

DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas

Central Nervous System Diseases | Brain Cancer

United States
Legacy Health System
Total Contact

Completed

Hypertrophic Scarring After Facial Burn

Burn

United States
Rigshospitalet, Denmark

Not yet recruiting

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

Chronic Ischemic Heart Disease

Denmark
Oregon Social Learning Center
National Institute on Drug Abuse (NIDA)

Completed

Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy (R3)

Behavioral
Eli Lilly and Company

Completed

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Solid Tumors

United States
Regor Pharmaceuticals Inc.

Recruiting

A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors

Breast Cancer | Advanced Solid Tumor

China
University of Barcelona
Universitat Oberta de Catalunya

Completed

Virtual-self Identity Construal in Online Video Games: A Repertory Grid Study

General Population

Spain
Lenus Therapeutics, LLC

Terminated

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

Dystrophic Epidermolysis Bullosa | Junctional Epidermolysis Bullosa

United States
RegeneRx Biopharmaceuticals, Inc.
sigma-tau i.f.r. S.p.A.

Completed

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers (SSVS)

Venous Stasis Ulcers

Italy, Poland
Universitat Pompeu Fabra
Hospital Universitari Joan XXIII de Tarragona.

Completed

Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)

Hemiparesis
Oregon Social Learning Center
National Institute on Drug Abuse (NIDA)

Completed

Oregon Supplement: Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy

Evidence-Based Practice

United States
PT Bio Farma

Completed

Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates

Rotavirus Gastroenteritis

Indonesia
University of Lausanne Hospitals
Swiss Heart Foundation

Recruiting

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Inflammation | Carotid Artery Diseases | Atheromatous Plaques

Switzerland
Tel-Aviv Sourasky Medical Center
Fruitura Bioscience Ltd.

Completed

The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension (RGC)

Hypertension

Israel
Regimmune Corporation

Completed

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHD

United States
Contamac Ltd
Hartwig Research Center

Completed

Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Roflufocon D

Ametropia

Germany
Eli Lilly and Company

Terminated

A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor (GIST)

United States, Belgium, Germany, Netherlands, Poland, Spain
AbbVie

Recruiting

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

CNV | AMD | nAMD | Wet Age-related Macular Degeneration | wAMD | WetAMD

United States, Puerto Rico, Canada
University of British Columbia

Completed

Decentering and Relapse/Recurrence in MBCT for Depression in Adults

Depression | Depressive Disorder, Major | Depression in Remission

Canada
ReGenTree, LLC

Terminated

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Neurotrophic Keratopathy

United States
Michiel Kuijpers

Completed

Single-port Thoracoscopic Sympathicotomy for Treatment of Raynaud's Phenomenon, a Feasibility Study

Raynauds

Netherlands
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes

Healthy

India
Universitat Pompeu Fabra
Hospital de la Esperanza

Completed

Smart Autonomous Neuro-Rehabilitation System (SANaR)

Cognition Disorders | Cognitive Deficits
QIAGEN Gaithersburg, Inc
Amgen

Recruiting

Therascreen® KRAS RGQ PCR Kit

Colo-rectal Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

Non-small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Colorectal Cancer | Non-Small Cell Lung Cancer

United Kingdom
Siemens Molecular Imaging

Completed

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug (K5-101)

Non-squamous Non-small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Colon/Rectum Cancer

United States
Maastricht Radiation Oncology

Recruiting

The Effect of 360° Virtual Reality Movies on Fear and Anxiety (ENGAGE)

Breast Cancer | Head and Neck Cancer | Anxiety | Lung Cancer | Prostate Cancer | Brain Tumor | Fear

Netherlands
Federal University of Piaui

Recruiting

Effect of the Use of Low Intensity Therapeutic LASER

Diabetic Foot | Wound | LTBI

Brazil
Federal University of Piaui

Completed

Use of Low-level Laser Therapy in the Treatment of Diabetic Foot Ulcers

Diabetic Foot | Diabetic Foot Ulcer

Brazil
AdventHealth
Integra LifeSciences Corporation

Withdrawn

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Prostate Cancer | Prostatectomy | Incontinence, Urinary | Erectile Dysfunction Following Radical Prostatectomy

United States
Genexine, Inc.

Completed

Phase I Study GX-G3 in Healthy Subjects (GX-G3)

Healthy

Korea, Republic of
REGENXBIO Inc.

Active, not recruiting

A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501

Homozygous Familial Hypercholesterolemia (HoFH)

United States, Canada, Netherlands
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Non Small Cell Lung Cancer

United Kingdom
Rigshospitalet, Denmark

Unknown

Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer (RaPiCCa)

Cervical Cancer

Denmark
Paragon Vision Sciences

Completed

High Refractive Index Material 510(k) (PVS-07-07)

Myopia | Hyperopia

United States
Örebro University, Sweden
NutriLeads B.V. (Wageningen, The Netherlands); ProDigest (Ghent, Belgium); Ambiotis...

Recruiting

Towards a Food Ingredient Clinically Proven to Benefit Gut Health: Novel RG-I Variants (NUTRIGUT)

Healthy

Sweden
National Cancer Institute (NCI)

Not yet recruiting

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Human Papillomavirus-Related Carcinoma

United States, Austria
Massachusetts General Hospital
Crico; Inspiren Inc; RGI Informatics LLC

Not yet recruiting

Predictive Analytics and Computer Visualization Enhances Patient Safety to Prevent Falls

Falls and Falls With Injury
Glaukos Corporation

Terminated

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (GCF-041)

Glaucoma, Open-Angle

Germany
ReGenTree, LLC

Completed

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 (ARISE-3)

Dry Eye | Dry Eye Syndromes

United States
ReGenTree, LLC

Completed

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1

Dry Eye Syndrome

United States
Eli Lilly and Company

Completed

Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors

Metastasis | Malignancy

Japan
University of Lausanne Hospitals

Recruiting

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Myocardial Infarction, Acute | Chronic Ischemic Heart Disease | Myocardial Reperfusion

Switzerland
University Hospital, Linkoeping

Completed

Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease (RGM/PD)

Parkinson Disease

Sweden
ReGenTree, LLC

Completed

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2

Dry Eye Syndrome

United States
University of Wisconsin, Madison

Completed

A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers (UWI-02)

Healthy Volunteers

United States

Search clinical trials for: Rg3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations